Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Biohaven is an innovative U.S.-based biopharmaceutical company specializing in the development of novel therapies for neurological diseases. The company focuses on researching groundbreaking medications to improve the quality of life for patients living with rare conditions and complex medical disorders.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Biohaven is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Biohaven last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.91 USD.
Across its last 3 earnings reports, Biohaven stock moved by ±5% on average the following day. The largest reaction was -9.7% on 03/02/2026; 0 of 3 reactions were positive.
Biohaven has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.